MONDAY, Dec. 20, 2021 (HealthDay News) — The maker of the pricey new Alzheimer’s drug Aduhelm (aducanumab) said Monday it will slash the cost of its medication in half, effective Jan. 1, 2022. The move follows widespread criticism of the drug’s original $56,000-a-year price tag. The reduction in the wholesaleContinue Reading

TUESDAY, Dec. 7, 2021 (HealthDay News) — People who undergo surgery to treat cataracts may have a lower likelihood of developing Alzheimer’s disease, a new study suggests. Of more than 3,000 older adults with the eye disease, those who had surgery were about 30% less likely to be diagnosed withContinue Reading

MONDAY, Dec. 6, 2021 (HealthDay News) — Checking older adults’ resting heart rate could help identify those who are more likely to experience a decline in mental function, a Swedish study suggests. The researchers found that a high resting heart rate was associated with a greater risk of dementia. “WeContinue Reading

TUESDAY, Nov. 30, 2021 (HealthDay News) — Coffee lovers know a steaming cup of java can quickly deliver energy and mental clarity every morning, but new research suggests it may also guard against Alzheimer’s disease in the long run. “Worldwide, a high proportion of adults drink coffee every day, makingContinue Reading

FRIDAY, Nov. 16, 2021 (HealthDay News) — Low-dose aspirin neither reduces nor increases the risk of dementia in adults with type 2 diabetes, a new study finds. “This is reassuring that an increase in the risk of dementia is unlikely for the millions of people worldwide who regularly take aspirinContinue Reading

THURSDAY, Nov. 18, 2021 (HealthDay News) — Neurologists must make sure Alzheimer’s patients and their families understand that the controversial drug aducanumab does not restore mental function, the American Academy of Neurology (AAN) said in new position statement that includes ethical guidelines. “Aducanumab is not a cure for Alzheimer’s disease,Continue Reading

THURSDAY, Nov. 18, 2021 (HealthDay News) — Despite stereotypes about seniors and technology, a small study suggests that older adults in the early stages of dementia can use smartphone apps as memory aids. The researchers found that older people with mild impairments in memory and thinking were not only ableContinue Reading

WEDNESDAY, Nov. 17, 2021 (HealthDay News) — The first human clinical trial of a nasal vaccine to slow the progression of Alzheimer’s disease is set to begin after nearly 20 years of research. This is a “remarkable milestone,” according to Dr. Howard Weiner, co-director of the Ann Romney Center forContinue Reading

MONDAY, Nov. 15, 2021 (HealthDay News) — A new and expensive Alzheimer’s drug called Aduhelm is responsible for about half of the $21.60 increase in monthly premiums for Medicare’s Part B outpatient program in 2022, Medicare officials report. The new premium will be $170.10 a month, and the $21.60 boostContinue Reading

FRIDAY, Nov. 12, 2021 (HealthDay News) — Alzheimer’s is a devastating disease, slowly robbing patients of their memories and even their sense of selves. Now, new research shows it also robs sufferers of a healthy social life. “Social relationships are an essential feature of our quality of life and canContinue Reading